Evidence map›Paper›PMID 36001862›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets.

Chiara Herzog, Fátima Marín, Allison Jones, Iona Evans, Daniel Reisel, Elisa Redl, Lena Schreiberhuber, Sonia Paytubi, Beatriz Pelegrina, Álvaro Carmona and 21 more

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06672341 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

A Prospective, Open, Observational Clinical Study on Endometrial Cytology and Cervical Methylation Testing for Screening and Evaluating Fertility-Sparing Treatment in Endometrial Cancer

Typeobservational_patient_registrySponsorYulan RenRan2024 to 2026Enrolled200ConditionsEndometrial Cancer, Methylation, Cytology, Fertility PreservationArmsEndometrial Cytology Testing, Cervical Methylation Testing
NCT06846775 recruitingnot on this mapstarted 2025, after this paper: background citation

A Case-control Study of the Clinical Utility of DNA Methylation Testing in Patient-collected Vaginal and Urine Samples: A Novel, Patient-friendly and Simple Diagnostic Solution to Detect Endometrial Cancer.

Typeobservational_patient_registrySponsorUniversity of AarhusRan2025 to 2028Enrolled120ConditionsEndometrial CancerArmsDNA-methylation testing in patient-collected urine and vaginal samples
NCT07400835 recruitingnot on this mapstarted 2026, after this paper: background citation

The ENDOMETRIAL Study: EvaluatioN of DNA methylatiOn Markers for EndomeTrial Cancer Risk-stratification Using Patient-collected urIne and vAginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal bLeeding

Typeobservational_patient_registrySponsorUniversity of AarhusRan2026 to 2030Enrolled600ConditionsPostmenopausal BleedingArmsDNA-methylation testing in patient-collected urine and vaginal samples and clinician-collected cervical samples
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 10 institutions in 6 countries.

Chiara HerzogEuropean Translational Oncology Prevention and Screening (EUTOPS) Institute, Universität Innsbruck, Innsbruck, Austria.ORCID 0000-0002-1572-498X
Fátima MarínHereditary Cancer Group, Catalan Institute of Oncology, IDIBELL, ONCOBELL Program, L'Hospitalet, Barcelona, Spain.ORCID 0000-0003-3534-0091
Allison JonesDepartment of Women's Cancer, University College London, London, United Kingdom.
Iona EvansDepartment of Women's Cancer, University College London, London, United Kingdom.
Daniel ReiselDepartment of Women's Cancer, University College London, London, United Kingdom.
Elisa RedlEuropean Translational Oncology Prevention and Screening (EUTOPS) Institute, Universität Innsbruck, Innsbruck, Austria.
Lena SchreiberhuberEuropean Translational Oncology Prevention and Screening (EUTOPS) Institute, Universität Innsbruck, Innsbruck, Austria.ORCID 0000-0003-3065-9888
Sonia PaytubiCancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-5392-953X
Beatriz PelegrinaCancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-9832-1165
Álvaro CarmonaCancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-5442-6117
Paula Peremiquel-TrillasCancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-8636-1725
Jon Frias-GomezCancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Marta PinedaHereditary Cancer Group, Catalan Institute of Oncology, IDIBELL, ONCOBELL Program, L'Hospitalet, Barcelona, Spain.ORCID 0000-0002-5403-5845
Joan BrunetHereditary Cancer Group, Catalan Institute of Oncology, IDIBELL, ONCOBELL Program, L'Hospitalet, Barcelona, Spain.ORCID 0000-0003-1945-3512
Jordi PonceConsortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health, Madrid, Spain.ORCID 0000-0002-0613-2261
Xavier Matias-GuiuConsortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health, Madrid, Spain.
Silvia de SanjoséISGlobal, Barcelona, Spain.
Laia AlemanyCancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Adeola OlaitanUniversity College Hospital, London, United Kingdom.
Michael WongUniversity College Hospital, London, United Kingdom.ORCID 0000-0002-2168-1111
Davor JurkovicUniversity College Hospital, London, United Kingdom.
Emma J CrosbieDepartment of Obstetrics and Gynaecology, Manchester Academic Health Science Center, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.ORCID 0000-0003-0284-8630
Adam N RosenthalDepartment of Women's Cancer, University College London, London, United Kingdom.
Line BjørgeDepartment of Obstetrics and Gynaecology, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0002-0240-2770
Michal ZikanDepartment of Gynecology and Obstetrics, Charles University in Prague, First Faculty of Medicine and Bulovka University Hospital, Czech Republic.ORCID 0000-0001-5266-8895
Lukas DostalekDepartment of Obstetrics and Gynecology, First Faculty of Medicine, Gynaecologic Oncology Center, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.ORCID 0000-0003-0151-4559
David CibulaDepartment of Obstetrics and Gynecology, First Faculty of Medicine, Gynaecologic Oncology Center, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.ORCID 0000-0001-6387-9356
Karin SundströmDivision of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-6865-0224
Joakim DillnerDivision of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-8588-6506
Laura CostasCancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Martin WidschwendterEuropean Translational Oncology Prevention and Screening (EUTOPS) Institute, Universität Innsbruck, Innsbruck, Austria.ORCID 0000-0002-7778-8380
Institut d'Investigació Biomédica de Bellvitge · ESUniversität Innsbruck · ATUniversity College London · GBCharles University · CZUniversity College Hospital · GBBellvitge University Hospital · ESKarolinska Institutet · SEBarcelona Institute for Global Health · ESHaukeland University Hospital · NOUniversity of Manchester · GB

Funding

Department of Health IS-BRC-1215-20007
6 · The paper itself

Abstract

purposeEndometrial cancer (EC) incidence has been rising over the past 10 years. Delays in diagnosis reduce survival and necessitate more aggressive treatment. We aimed to develop and validate a simple, noninvasive, and reliable triage test for EC to reduce the number of invasive diagnostic procedures and improve patient survival.

methodsWe developed a test to screen and triage women with suspected EC using 726 cervical smear samples from women with and without EC, and validated the test in 562 cervicovaginal samples using three different collection methods (cervical smear: n = 248; vaginal swab: n = 63; and self-collection: n = 251) and four different settings (case/control: n = 388; cohort of women presenting with postmenopausal bleeding: n = 63; a cohort of high-risk women with Lynch syndrome: n = 25; and a nested case/control setting from a screening cohort and samples taken up to 3 years before EC diagnosis: n = 86).

resultsWe describe the

conclusionThe WID-qEC is a noninvasive reliable test for triage of women with symptoms suggestive of ECs. Because of the potential for self-collection, it could improve early diagnosis and reduce the reliance for in-person visits.

Indexed as

Endometrial NeoplasmsPapillomavirus InfectionsUterine Cervical NeoplasmsEarly Detection of CancerEpigenesis, GeneticFemaleHumansTriageVaginal Smears

Identifiers

PMID36001862
PMCPMC9671754
OpenAlexW4292994868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.